Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,177B 7.39B 6.74B 6.23B 5.62B 10.59B 691B 11.01B 75.27B 29.75B 373B 27.73B 27.15B P/E 2027 *
15.6x
P/E 2028 * 18.2x
Enterprise Value 975B 6.12B 5.58B 5.16B 4.66B 8.77B 572B 9.12B 62.35B 24.65B 309B 22.97B 22.49B EV / Sales 2027 *
2.11x
EV / Sales 2028 * 2.06x
Free-Float
82.24%
Yield 2027 *
3.19%
Yield 2028 * 3.19%
1 day+0.60%
1 week+3.30%
Current month+10.99%
1 month+3.71%
3 months+2.60%
6 months+2.56%
Current year+15.26%
1 week 2,438
Extreme 2438
2,538
1 month 2,111.5
Extreme 2111.5
2,565.5
Current year 2,111.5
Extreme 2111.5
2,674.5
1 year 2,014
Extreme 2014
2,674.5
3 years 1,474
Extreme 1474
2,849
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 68 2024-03-31
Director of Finance/CFO - 2026-03-31
President 57 2024-03-31
Director TitleAgeSince
Chairman 68 2024-03-31
Director/Board Member 57 2020-05-31
Director/Board Member 77 2018-06-25
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%+3.30%+24.73%-6.74% 7.35B
-2.02%-4.88%+29.35%+127.18% 1,232B
-2.12%-5.75%+31.96%+78.26% 656B
-1.23%-4.11%+21.23%+104.15% 506B
-1.04%-1.80%+28.69%+68.33% 382B
-2.87%-8.63%+41.27%+30.77% 340B
-3.22%-5.20%+24.48%+50.97% 294B
-2.51%-4.49%-2.15%+31.64% 278B
-1.03%-5.44%+28.98%+66.44% 240B
-1.24%-0.37%+30.66%+120.17% 210B
Average -1.65%-1.80%+25.92%+67.12% 414B
Weighted average by Cap. -1.93%-2.66%+27.27%+87.37%

Financials

2027 *2028 *
Net sales 463B 2.91B 2.65B 2.45B 2.21B 4.17B 272B 4.33B 29.6B 11.7B 147B 10.9B 10.68B 449B 2.82B 2.57B 2.38B 2.14B 4.04B 263B 4.2B 28.69B 11.34B 142B 10.57B 10.35B
Net income 75.66B 475M 433M 401M 361M 681M 44.39B 708M 4.84B 1.91B 23.96B 1.78B 1.74B 64.66B 406M 370M 342M 309M 582M 37.94B 605M 4.13B 1.63B 20.48B 1.52B 1.49B
Net Debt -202B -1.27B -1.16B -1.07B -965M -1.82B -119B -1.89B -12.92B -5.11B -63.97B -4.76B -4.66B -251B -1.58B -1.44B -1.33B -1.2B -2.26B -148B -2.35B -16.08B -6.35B -79.61B -5.92B -5.8B
Projected Income Statement - Annual - Ono Pharmaceutical Co., Ltd.
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
26-11-19 JP¥2,504.00 +0.60% 1,061,400
26-11-18 JP¥2,489.00 -0.12% 1,497,900
26-11-17 JP¥2,492.00 -0.44% 1,224,500
26-11-16 JP¥2,503.00 +1.25% 1,080,000
26-11-13 JP¥2,472.00 -0.58% 1,199,000
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ono Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,504.00JPY
Average target price
2,512.50JPY
Spread / Average Target
+0.34%
  1. Stock Market
  2. Stocks
  3. 4528 Stock